We are blurring the boundaries between our EDC and RTSM (Randomization and Trial Supply Management) applications. Our combined EDC-RTSM solution brings about a radical shift in the way technology applications can be used together in clinical trials. This complete technology solution is created from the combination of DataLabs®, our leading EDC solution, and ClinPhone® RTSM, our proven IVR/IWR applications. By building tight integration between RTSM and EDC, we have enabled EDC, along with the phone (IVR) and the web (IWR), to be used as another interface to our RTSM application.
Site users can randomize and dispense medication in real time through the EDC solution, using a robust real-time integration. Users can conveniently perform these activities without logging into another system. These advanced capabilities achieve true interoperability, blurring the traditional boundaries between applications which interrupt efficient user workflow. Our enhanced functionality means users benefit from significantly simplified workflow, saving time and effort when utilizing both solutions.
Underpinned by cutting-edge, advanced functionality and our unique Clinical Technology Integration Platform (CTIP), Perceptive brings together all the key clinical trial technology components under one roof. Your study teams benefit from having a single project manager, coordinating all the activities required to design and apply the technology solution, and a single in-house 24/7 help desk. Why work with anyone else?
The Perceptive Virtual Panel System (VPS) is a web-based application that combines the functionality of a document repository with electronic data capture. Perceptive’s VPS facilitates an automated independent event review process, including efficient dossier management and event adjudication throughout.
Perceptive is one of the leading providers of key technology components to support adaptive trials, integrating EDC, ePRO, IVR, supplies simulation and forecasting. Perceptive provides expert consulting on supplies planning and optimal technology implementation for adaptive trials.